Walter Albrecht - Concepedia

Author

Walter Albrecht

European Organisation for Research and Treatment of Cancer

Also Known As

NTD Study Group, W E Albrecht, Walter Albrecht

Publications

5.5K

Citations

H-Index

Concepts

All Affiliations

European Organisation for Research and Treatment of Cancer Krankenanstalt Rudolfstiftung der Stadt Wien Ospedale di Circolo e Fondazione Macchi Rudolfinerhaus Hospital San Raffaele University of Rome

About

Walter Albrecht is an author at European Organisation for Research and Treatment of Cancer specializing in medicine, oncology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	3.3K
2	Surgical Oncology	4	4	2.8K
3	Nephrology	2	2	2.1K
4	Pathology	2	2	278
5	Anesthesia	1	1	17

Walter Albrecht

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
A Prospective Randomized EORTC Intergroup Phase 3 Study Comparing the Complications of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma Hendrik Van Poppel, L. Da Pozzo, Walter Albrecht, European Urology UrologySurgical OncologyGenitourinary CancerMedicineKidney Failure	2006	1K
A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma Hendrik Van Poppel, L. Da Pozzo, Walter Albrecht, European Urology UrologySurgical OncologyOncologic OutcomeGenitourinary CancerMedicine	2010	1K
Guidelines on Testicular Cancer: 2015 Update Peter Albers, Walter Albrecht, Ferrán Algaba, European Urology AndrologySurgical OncologyUrologyGenitourinary CancerTesticular Cancer	2015	662
Immediate or Deferred Androgen Deprivation for Patients With Prostate Cancer Not Suitable for Local Treatment With Curative Intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891 Urs E. Studer, Peter Whelan, Walter Albrecht, Journal of Clinical Oncology	2006	330
European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II S. Krege, J. Beyer, Rainer Souchon, European Urology Germ Cell CancerGenitourinary CancerMedicineCancer ManagementEuropean Consensus Conference	2008	252
Using PSA to Guide Timing of Androgen Deprivation in Patients with T0–4 N0–2 M0 Prostate Cancer not Suitable for Local Curative Treatment (EORTC 30891) Urs E. Studer, Laurence Collette, Peter Whelan, European Urology UrologyEortc 30891Genitourinary CancerMedicineCancer Management	2007	151
Is Baseline Quality of Life Useful for Predicting Survival With Hormone-Refractory Prostate Cancer? A Pooled Analysis of Three Studies of the European Organisation for Research and Treatment of Cancer Genitourinary Group Laurence Collette, George van Andel, Andrew Bottomley, Journal of Clinical Oncology	2004	77
Intermittent Maximal Androgen Blockade in Patients with Metastatic Prostate Cancer: An EORTC Feasibility Study Walter Albrecht, Laurence Collette, C. Fava, European Urology Metastatic Prostate CancerUrologyGenitourinary CancerMedicinePharmacotherapy	2003	53
Radiotherapy of testicular intraepithelial neoplasia (TIN): a novel treatment regimen for a rare disease Felix Sedlmayer, W. Höltl, Walter Kozak, International Journal of Radiation OncologyBiologyPhysics Novel Treatment RegimenUrologySurgical OncologyRadiation TherapyRare Disease	2001	32
Prognostic role of N-cadherin expression in patients with non–muscle-invasive bladder cancer Mohammad Abufaraj, Shahrokh F. Shariat, Andrea Haitel, Urologic Oncology Seminars and Original Investigations Tumor BiologyUrologyPrognostic RoleGenitourinary CancerMedicine	2017	26

Page 1